Novel Anti-Mitotic Peptides for the treatment of Cancer
- Technology Application
- Because cancer is characterized by abnormal cell proliferation and migration, agents that affect mitosis and cell migration have great therapeutic potential. However, existing agents with these properties such as Taxol and Colchicine act on all cell types and cause significant side effects. Thus there is a need for anti-mitotic agents with greater cell specificity and reduced toxicity.
- Detailed Technology Description
- Anti-mitotic peptides acting by preventing tubulin polymerization.
- *Abstract
-
None
- Country/Region
- USA
For more information, please click Here
